Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects

Clinical trial NCT05088343 · COMPLETED

Trial details

NCT number: NCT05088343
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2020-09-07
Primary completion: 2021-01-16
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.